Literature DB >> 11100981

AT-1 receptor and phospholipase C are involved in angiotensin III modulation of hypothalamic noradrenergic transmission.

M Rodriguez-Campos1, C Kadarian, V Rodano, L Bianciotti, B Fernandez, M Vatta.   

Abstract

1. We previously reported that angiotensin III modulates noradrenergic neurotransmission in the hypothalamus of the rat. In the present work we studied the effects of angiotensin III on norepinephrine release and tyrosine hydroxylase activity. We also investigated the receptors and intracellular pathways involved in angiotensin III modulation of noradrenergic transmission. 2. In rat hypothalamic tissue labeled with [3H]norepinephrine 1, 10, and 100 nM and 1 microM losartan (AT1 receptor antagonist) had no effect on basal neuronal norepinephrine release, whereas 10 and 100 nM and 1 microM losartan partially diminished norepinephrine secretion evoked by 25 mM KCl. The AT2 receptor antagonist PD 123319 showed no effect either on basal or evoked norepinephrine release. The increase in both basal and evoked norepinephrine output induced by 1 microM angiotensin III was blocked by 1 microM losartan, but not by 1 microM PD 123319. 3. The phospholipase C inhibitor 5 microM neomicin inhibited the increase in basal and evoked norepinephrine release produced by 1 microM angiotensin III. 4. Tyrosine hydroxylase activity was increased by 1 microM angiotensin III and this effect was blocked by 1 microM LST and 5 microM neomicin, but not by PD 123319. On the other hand, 1 microM angiotensin III enhanced phosphatidyl inositol hydrolysis that was blocked by 1 microM losartan and 5 microM neomicin. PD 123319 (1 microM) did not affect ANG III-induced phosphatidyl inositol hydrolysis enhancement. 5. Our results confirm that angiotensin III acts as a modulator of noradrenergic transmission at the hypothalamic level through the AT1-phospholipase C pathway. This enhancement of hypothalamic noradrenergic activity suggests that angiotensin III may act as a central modulator of several biological processes regulated at this level by catecholamines, such as cardiovascular, endocrine, and autonomic functions as well as water and saline homeostasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11100981     DOI: 10.1023/a:1007059010571

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  37 in total

1.  Effects of atrial natriuretic peptide and angiotensin III on the uptake and intracellular distribution of norepinephrine in medulla oblongata of the rat.

Authors:  M S Vatta; L G Bianciotti; M L Papouchado; A S Locatelli; B E Fernández
Journal:  Comp Biochem Physiol C       Date:  1991

Review 2.  Cytoskeleton dynamics during neurotransmitter release.

Authors:  J M Trifaró; M L Vitale
Journal:  Trends Neurosci       Date:  1993-11       Impact factor: 13.837

3.  Long-term effects of preganglionic nerve stimulation on tyrosine hydroxylase activity in the rat superior cervical ganglion.

Authors:  R E Zigmond; A Chalazonitis
Journal:  Brain Res       Date:  1979-03-23       Impact factor: 3.252

4.  Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.

Authors:  S Zini; M C Fournie-Zaluski; E Chauvel; B P Roques; P Corvol; C Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 5.  Synaptic vesicles and exocytosis.

Authors:  R Jahn; T C Südhof
Journal:  Annu Rev Neurosci       Date:  1994       Impact factor: 12.449

6.  Effects of Ca2+ on phosphoinositide breakdown in exocrine pancreas.

Authors:  C W Taylor; J E Merritt; J W Putney; R P Rubin
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

7.  Losartan inhibits sympathetic and cardiovascular responses to carotid occlusion.

Authors:  K Kumagai; I A Reid
Journal:  Hypertension       Date:  1994-06       Impact factor: 10.190

Review 8.  Neurobiology of central angiotensin III and dipsogenesis.

Authors:  C C Yang; T B Kuo; S H Chan; J Y Chan
Journal:  Biol Signals       Date:  1995 Mar-Apr

9.  Enhanced pressor response to angiotensin III in spontaneously hypertensive rats: effects of losartan.

Authors:  R Radhakrishnan; M K Sim
Journal:  Eur J Pharmacol       Date:  1994-06-23       Impact factor: 4.432

Review 10.  Scinderin and chromaffin cell actin network dynamics during neurotransmitter release.

Authors:  J M Trifaró; M L Vitale; A Rodríguez Del Castillo
Journal:  J Physiol Paris       Date:  1993
View more
  1 in total

Review 1.  Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives.

Authors:  Shereeni J Veerasingham; Mohan K Raizada
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.